Intellia Therapeutics (NTLA) SEC Filings & 10K Form

$21.17
-0.36 (-1.67%)
(As of 04/24/2024 ET)

Recent Intellia Therapeutics SEC Filings

DateFilerForm TypeView
04/22/2024
3:10 PM
Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/15/2024
3:21 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
8:26 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
6:04 AM
Intellia Therapeutics (Filer)
Form 424B5
02/23/2024
4:22 PM
Intellia Therapeutics (Filer)
Form 424B5
02/23/2024
4:17 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
3:00 PM
ARK Investment Management LLC (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
01/24/2024
10:21 AM
Intellia Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/10/2024
3:15 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:35 PM
BlackRock Inc. (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
01/05/2024
3:44 PM
Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:45 PM
BASTA JAMES (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:46 PM
Hicks Derek (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:49 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:50 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:50 PM
Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:51 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
4:28 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:30 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:34 PM
Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:35 PM
Intellia Therapeutics (Issuer)
Sepp-Lorenzino Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
7:09 PM
Crowley John F (Reporting)
Intellia Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
6:00 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
8:30 AM
Intellia Therapeutics (Filer)
Form S-3ASR
11/09/2023
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:42 PM
Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
6:11 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
6:30 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
6:19 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
3:13 PM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2023
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2023
4:19 PM
Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2023
3:45 PM
Bhanji Muna (Reporting)
Intellia Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2023
4:21 PM
Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:22 PM
Bhanji Muna (Reporting)
Intellia Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/06/2023
2:34 PM
Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
4:52 PM
Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
6:39 PM
Clark Eliana (Reporting)
Intellia Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2023
3:24 PM
Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
One trade. One ticker. One week. (Ad)

Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week?

Well, then you should click here to see this free training.
06/16/2023
3:26 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:13 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2023
6:00 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
3:52 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2023
6:41 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NTLA) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners